|
(Health-NewsWire.Net, July 20, 2022 ) According to a new market research report “Precision Medicine Software Market by Deployment Mode (On-premise, Cloud-based), Application (Oncology, Pharmacogenomics, CNS), End User (Healthcare Providers, Research, Academia, Pharma, Biotech) - Forecast to 2028”, published by Meticulous Research®, the precision medicine software market is expected to grow at a CAGR of 11.2% from 2021 to 2028 to reach $2.55 billion by 2028.
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5011
Precision medicine software comprises on-premise and web & cloud-based deployment platforms used in the personalized treatment and detection of diseases, such as cancers, genetic disorders, cardiac & infectious diseases, and others. Precision medicine software assists physicians in choosing a treatment method based on the patient’s genetic makeup and lifestyle habits.
The paradigm shifts in treatment, rising pressure to decrease healthcare costs, scientific & technological advances in the genomics field, and growing focus towards providing companion diagnostics & biomarkers for various therapeutic areas are some of the major factors expected to drive the growth of this market. However, the lack of awareness about precision medicine practices and fragmented healthcare systems in developing countries hinder the growth of this market to a certain extent.
The overall precision medicine software market is segmented based on deployment mode, application, end user, and geography.
Speak to our Analysts to Understand the Impact of COVID-19 on Your Business: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5011
Based on deployment mode, the precision medicine software market is categorized into on-premise and web & cloud-based. In 2021, the on-premise segment is estimated to account for the largest share of the overall precision medicine software market. The large share of this segment is primarily attributed to the broad range of advantages associated with the use of on-premise software, such as high security of data, low risk of data breaches, and full command over software upgrades & data storage. In addition, higher adoption among end-users and flexibility with connection bandwidth further support the growth of the segment.
Based on application, the precision medicine software market is mainly segmented into oncology, pharmacogenomics, central nervous system disorders, hereditary disorders, and cardio & metabolic disorders. In 2021, the oncology segment is estimated to account for the largest share of the overall precision medicine software market. The large share of this segment is primarily attributed to the growing prevalence of cancer, shift towards personalized treatment, rising funding in cancer research, applications of precision medicine in oncology research, and increased investments by government organizations in precision medicine and related software industry.
Quick Buy – Precision Medicine Software Market Research Report: https://www.meticulousresearch.com/Checkout/77677182
Based on end user, the precision medicine software market is categorized into healthcare providers, research and government institutes, and pharmaceutical & biotechnology companies. In 2021, the healthcare providers segment is estimated to account for the largest share of the overall precision medicine software market. The large share of this segment is primarily attributed to the rising number of tertiary/specialty care hospitals, rising incidence of chronic diseases, growing healthcare infrastructure, increasing demand for quality healthcare, and shift towards personalized/precision medicine.
Based on geography, the global precision medicine software market is categorized into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with a further analysis of major countries in these regions. In 2021, North America region is estimated account for the largest share of the overall precision medicine software market. However, the Asia-Pacific region is expected to register the highest growth during the forecast period. The growing shift in treatment from one-size-fits-all medicines to precision medicine, increased spending on healthcare, rising funds for research activities, and growing focus of international players to expand their presence in this region are some of the key factors expected to propel the growth of the precision medicines software market in Asia-Pacific.
The key players operating in the global precision medicine software market are Syapse, Inc. (U.S.), Fabric Genomics, Inc. (U.S.), SOPHiA GENETICS SA (Switzerland), Human Longevity, Inc. (U.S.), Sunquest Information Systems Inc. (U.S.), LifeOmic Health, LLC (U.S.), Translational Software Inc. (U.S.), N-of-One Inc. (U.S.), PhenoTips (Canada), PierianDx Inc. (U.S.), Foundation Medicine, Inc. (U.S.), 2bPrecise, LLC (U.S.), and GenomOncology LLC (U.S.), among others.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/precision-medicine-software-market-5011
Scope of the Report:
Precision Medicine Software Market, by Delivery Mode
On-premise
Web & Cloud-based
Precision Medicine Software Market, by Application
Oncology
Pharmacogenomics
Other Applications
Precision Medicine Software Market, by End User
Healthcare Providers
Research & Government Institutes
Pharmaceutical & Biotechnology Companies
Precision Medicine Software Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Middle East and Africa
Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5011
Meticulous Research™
Khushal
+91 744-7780008
sales@meticulousresearch.com
Source: EmailWire.Com 
|
